Our voting records

Search our voting records

Below you will find a fully searchable table of our UK and European voting records, going back as far as 2004 (note that we only started disclosing our European votes in December 2011). You can view all resolutions where we voted against or abstained for each individual company by selecting from the drop-down list, or view the comments on the vote cast by selecting the resolution detail link. Where we have not supported a board's recommendations, a brief explanation is included.

We make the voting records available monthly, two weeks in arrears. If you have any problems using the search facility please don’t hesitate to contact us.

Search

Company:
Month:
Year:

Voting records
		Resolution
Meeting Type	Company	No.	Detail	Vote Cast	Country
04/04/2013 Annual	Volvo AB	18	Amend Articles Re: Insert Gender Quota for Board of Directors Shareholder Proposal Not in shareholders’ best interests.	Against	Sweden
04/04/2013 Annual	Volvo AB	19	Request Board to Consider Increasing Apprenticeships Shareholder Proposal Not in shareholders’ best interests.	Against	Sweden
10/04/2013 Annual	Svenska Cellulosa Ab (Sca)	15	Amend Articles Re: Insert Gender Quota for Board of Directors Shareholder Proposal Not in shareholders’ best interests.	Against	Sweden
11/04/2013 Annual	BP plc	2	Approve Remuneration Report Remuneration Report Remuneration policy has the potential to reward executives for achieving unchallenging performance conditions.	Against	United Kingdom
11/04/2013 Annual	BP plc	8	Re-elect Antony Burgmans as Director Re-elect Director We voted against the re-election of the Remuneration Committee Chairman to emphasise and underline concerns regarding remuneration policy and practice.	Against	United Kingdom
11/04/2013 Annual	BP plc	10	Re-elect George David as Director Re-elect Director We abstained on the re-election of the Remuneration Committee member to emphasise and underline concerns regarding remuneration policy and practice.	Abstain	United Kingdom
11/04/2013 Annual	BP plc	11	Re-elect Ian Davis as Director Re-elect Director We abstained on the re-election of the Remuneration Committee member to emphasise and underline concerns regarding remuneration policy and practice.	Abstain	United Kingdom
11/04/2013 Annual	BP plc	12	Re-elect Dame Ann Dowling as Director Re-elect Director We abstained on the re-election of the Remuneration Committee member to emphasise and underline concerns regarding remuneration policy and practice.	Abstain	United Kingdom
11/04/2013 Annual/Special	Klepierre	4	Approve Auditors' Special Report on Related-Party Transactions Related Party Transactions Insufficient disclosure was provided on the detail of the transactions.	Against	France
11/04/2013 Annual/Special	Klepierre	8	Authorise Repurchase of Up to 5 Percent of Issued Share Capital Poison Pills/Anti-takeover devices We did not believe this to be in the best interests of all shareholders	Against	France
15/04/2013 Annual	Borregaard ASA	3.3	Approve Remuneration Policy And Other Terms of Employment For Executive Management (Binding) Remuneration Report Remuneration policies are not aligned with our interests as shareholders.	Against	Norway
15/04/2013 Annual	Borregaard ASA	6.1	Authorize Share Repurchase Program in Connection with Employee Incentive Programs Remuneration Report Remuneration policies are not aligned with our interests as shareholders.	Against	Norway
17/04/2013 Annual	Carnival plc	15	Advisory Vote to Approve Compensation of the Named Executive Officers Remuneration Report We did not feel it was appropriate that executives should receive bonuses on the basis that there were a number of incidents during the year involving the ships operated by the company. One of these resulted in customer fatalities, and others had a negative impact on the company’s reputation with its customers. The financial performance of the company was also affected.	Against	United Kingdom
17/04/2013 Annual	Carnival plc	16	Approve Remuneration Report Remuneration Report We did not feel it was appropriate that executives should receive bonuses on the basis that there were a number of incidents during the year involving the ships operated by the company. One of these resulted in customer fatalities, and others had a negative impact on the company’s reputation with its customers. The financial performance of the company was also affected.	Against	United Kingdom
18/04/2013 Annual	Adecco SA	1.2	Approve Remuneration Report Remuneration Report Remuneration policies are not aligned with our interests as shareholders.	Against	Switzerland
18/04/2013 Annual/Special	Altamir Amboise	4	Approve Auditors' Special Report Regarding New Related-Party Transactions Related Party Transactions Insufficient disclosure was provided on the detail of the transactions.	Against	France
18/04/2013 Annual/Special	Altamir Amboise	14	Amend Article 10 of Bylaws Re: Owners of Preferred Stock (B Shares) Amend Articles/Bylaws Not in shareholders’ best interests.	Against	France
18/04/2013 Annual/Special	Gecina	8	Authorise Repurchase of Up to 10 Percent of Issued Share Capital Poison Pills/Anti-takeover devices We did not believe this to be in the best interests of all shareholders	Against	France
18/04/2013 Annual/Special	Gecina	11	Approve Issuance of Equity or Equity-Linked Securities for up to 10 Percent of Issued Capital Per Year for Private Placements up to Aggregate Nominal Amount of EUR 50 Million Capital Structure Not in shareholders’ best interests as this authority does not reflect international best practice.	Against	France
18/04/2013 Annual/Special	Gecina	12	Authorise Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Capital Structure Not in shareholders’ best interests as this authority does not reflect international best practice.	Against	France
18/04/2013 Annual/Special	Gecina	13	Authorise Capital Increase of up to 10 Percent of Issued Capital for Future Acquisitions Capital Structure Not in shareholders’ best interests as this authority does not reflect international best practice.	Against	France
18/04/2013 Annual/Special	Gecina	15	Authorise Board to Set Issue Price for 10 Percent Per Year of Issued Capital Pursuant to Issue Authority without Preemptive Rights Capital Structure Not in shareholders’ best interests as this authority does not reflect international best practice.	Against	France
18/04/2013 Annual/Special	Gecina	17	Authorise up to 1.5 Percent of Issued Capital for Use in Stock Option Plan Executive Incentive Schemes Lack of disclosure on performance criteria	Against	France
18/04/2013 Annual/Special	Gecina	18	Authorise up to 1.5 Percent of Issued Capital for Use in Restricted Stock Plan Executive Incentive Schemes Lack of disclosure on performance criteria	Against	France
18/04/2013 Annual/Special	LVMH Moet Hennessy Louis Vuitton	3	Approve Auditors' Special Report on Related-Party Transactions Related Party Transactions We were not sufficiently reassured by the company that this would be fair to all shareholders	Against	France
18/04/2013 Annual/Special	LVMH Moet Hennessy Louis Vuitton	15	Authorise Issuance of Equity or Equity-Linked Securities without Pre-emptive Rights up to Aggregate Nominal Amount of EUR 50 Million Capital Structure Not in shareholders’ best interests as this authority does not reflect international best practice.	Against	France
18/04/2013 Annual/Special	LVMH Moet Hennessy Louis Vuitton	16	Approve Issuance of Shares up to 20 Percent of Issued Capital Per Year up to EUR 50 Million Reserved for Qualified Investors or Restricted Number of Investors Capital Structure Not in shareholders’ best interests as this authority does not reflect international best practice.	Against	France
18/04/2013 Annual/Special	LVMH Moet Hennessy Louis Vuitton	17	Authorise Board to Set Issue Price for 10 Percent Per Year of Issued Capital Pursuant to Issue Authority without Pre-emptive Rights Under Items 15 and 16 Above Capital Structure Not in shareholders’ best interests as this authority does not reflect international best practice.	Against	France
18/04/2013 Annual/Special	LVMH Moet Hennessy Louis Vuitton	18	Authorise Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Under Items 15 to 17 Capital Structure Not in shareholders’ best interests as this authority does not reflect international best practice.	Against	France
18/04/2013 Annual/Special	LVMH Moet Hennessy Louis Vuitton	19	Authorise Capital Increase of Up to EUR 50 Million for Future Exchange Offers Capital Structure Not in shareholders’ best interests as this authority does not reflect international best practice.	Against	France
18/04/2013 Annual/Special	LVMH Moet Hennessy Louis Vuitton	23	Authorise up to 1 Percent of Issued Capital for Use in Restricted Stock Plan Executive Incentive Schemes Lack of disclosure on performance criteria	Against	France
18/04/2013 Annual/Special	LVMH Moet Hennessy Louis Vuitton	24	Amend Article 18 and 29 of Bylaws Re: Related-Party Transactions, Stock Dividend Program Amend Articles/Bylaws It is our view that this bundled resolution included provisions that could weaken disclosure of related party transactions.	Against	France
18/04/2013 Annual	Persimmon plc	2	Approve Remuneration Report Ex-gratia Payments We do not support ex-gratia & other payments and financial awards to directors and former directors that are not within the terms of the company’s stated remuneration policy, unless such payments have been subject to prior approval by shareholders.	Against	United Kingdom
19/04/2013 Annual/Special	Banca Popolare dell'Emilia Romagna	2.1	Slate 1 Slate Nominees Shareholders can only vote in favour of one slate, and this slate does not best represent the interests of shareholders.	Against	Italy
19/04/2013 Annual/Special	Banca Popolare dell'Emilia Romagna	2.3	Slate 3 Slate Nominees Shareholders can only vote in favour of one slate, and this slate does not best represent the interests of shareholders.	Against	Italy
22/04/2013 Annual	BinckBank NV	8a	Amend Articles Re: Legislative Changes Amend Articles/Bylaws Not in shareholders’ best interests.	Against	Netherlands
22/04/2013 Annual	BinckBank NV	8b	Authorise Board Members and NautaDutilh N.V. to Ratify and Execute Approved Amendments Re: Item 8a Amend Articles/Bylaws Not in shareholders’ best interests.	Against	Netherlands
23/04/2013 Annual	Syngenta AG	1.2	Approve Remuneration Report Executive Incentive Schemes The incentive scheme appears to have no clear award policy and an absence of performance conditions.	Abstain	Switzerland
23/04/2013 Annual	TOMTOM NV	10	Approve Granting of Subscription Rights for Ordinary Shares under Employee Stock Option Plan and Management Board Stock Option Plan and Exclude Pre-emptive Rights Authorise Issued Capital for use in Incentive Plan The underlying features of this scheme did not reflect international best practice. We therefore did not support this authority to allocate shares to the scheme.	Against	Netherlands
23/04/2013 Annual	TOMTOM NV	11	Approve Call-Option Agreement with Company Friendly Foundation Poison Pills/Anti-takeover devices We did not believe this to be in the best interests of all shareholders	Against	Netherlands
23/04/2013 Annual	TOMTOM NV	14.ii	Amend Article 5.6 Re: Term to Convene General Meeting in Case of Issuances of Preference Shares Amend Articles/Bylaws Not in shareholders’ best interests.	Against	Netherlands
24/04/2013 Annual	AZIMUT HOLDING S.p.A.	6	Authorise Share Repurchase Program and Reissuance of Repurchased Shares Share Repurchase The structure of this authority was against best practice guidelines, therefore we were unsupportive.	Against	Italy
24/04/2013 Annual/Special	Anheuser-Busch InBev SA	A1c	Eliminate Pre-emptive Rights Re: Issuance of Subscription Rights Option awards to Non-executive Directors We do not believe that Non-executives should receive other remuneration in addition to their basic fees, given that their role is to constructively challenge and scrutinise management and contribute to the development of strategy.	Against	Belgium
24/04/2013 Annual/Special	Anheuser-Busch InBev SA	A1d	Approve Non-Employee Director Stock Option Plan: Issuance of 185,000 Warrants Option awards to Non-executive Directors We do not believe that Non-executives should receive other remuneration in addition to their basic fees, given that their role is to constructively challenge and scrutinise management and contribute to the development of strategy.	Against	Belgium
24/04/2013 Annual/Special	Anheuser-Busch InBev SA	A1e	Renew Authorisation to Increase Share Capital within the Framework of Authorised Capital: Issuance of Warrants under item A1d Option awards to Non-executive Directors We do not believe that Non-executives should receive other remuneration in addition to their basic fees, given that their role is to constructively challenge and scrutinise management and contribute to the development of strategy.	Against	Belgium
24/04/2013 Annual/Special	Anheuser-Busch InBev SA	A1f	Approve Deviation from Belgian Company Law Provision Re: Grant of Warrants to Non-Executive Directors Option awards to Non-executive Directors We do not believe that Non-executives should receive other remuneration in addition to their basic fees, given that their role is to constructively challenge and scrutinise management and contribute to the development of strategy.	Against	Belgium
24/04/2013 Annual/Special	Anheuser-Busch InBev SA	A1g	Authorise Implementation of Approved Resolutions and Filing of Required Documents/Formalities at Trade Registry Option awards to Non-executive Directors We do not believe that Non-executives should receive other remuneration in addition to their basic fees, given that their role is to constructively challenge and scrutinise management and contribute to the development of strategy.	Against	Belgium
24/04/2013 Annual/Special	Anheuser-Busch InBev SA	B9a	Approve Remuneration Report Remuneration Report Remuneration policies are not aligned with our interests as shareholders.	Against	Belgium
24/04/2013 Annual/Special	Anheuser-Busch InBev SA	B9b	Approve Stock Option Plan Grants Executive Incentive Schemes The structure of this scheme is not aligned with the interests of shareholders	Against	Belgium
24/04/2013 Annual	STV Group plc	9	Approve Value Creation Plan Executive Incentive Schemes The structure of this scheme is not aligned with the interests of shareholders	Abstain	United Kingdom
25/04/2013 Annual	Aggreko plc	2	Approve Remuneration Report Remuneration Report Remuneration policies are not aligned with our interests as shareholders.	Abstain	United Kingdom
25/04/2013 Annual/Special	Bouygues	4	Approve Auditors' Special Report on Related-Party Transactions Related Party Transactions Insufficient disclosure was provided on the detail of the transactions.	Against	France
25/04/2013 Annual/Special	Bouygues	15	Authorise Repurchase of Up to 5 Percent of Issued Share Capital Poison Pills/Anti-takeover devices We did not believe this to be in the best interests of all shareholders	Against	France
25/04/2013 Annual/Special	Bouygues	19	Authorise Issuance of Equity or Equity-Linked Securities without Pre-emptive Rights up to Aggregate Nominal Amount of EUR 150 Million Capital Structure Not in shareholders’ best interests as this authority does not reflect international best practice.	Against	France
25/04/2013 Annual/Special	Bouygues	20	Approve Issuance of Equity or Equity-Linked Securities for up to 20 Percent of Issued Capital Per Year for Private Placements, up to Aggregate Nominal Amount of EUR 150 Million Capital Structure Not in shareholders’ best interests as this authority does not reflect international best practice.	Against	France
25/04/2013 Annual/Special	Bouygues	21	Authorise Board to Set Issue Price for 10 Percent Per Year of Issued Capital Pursuant to Issue Authority without Preemptive Rights Capital Structure Not in shareholders’ best interests as this authority does not reflect international best practice.	Against	France
25/04/2013 Annual/Special	Bouygues	22	Authorise Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Above Capital Structure Not in shareholders’ best interests as this authority does not reflect international best practice.	Against	France
25/04/2013 Annual/Special	Bouygues	24	Authorise Capital Increase of Up to EUR 150 Million for Future Exchange Offers Capital Structure Not in shareholders’ best interests as this authority does not reflect international best practice.	Against	France
25/04/2013 Annual/Special	Bouygues	25	Authorise Issuance of Equity upon Conversion of a Subsidiary's Equity-Linked Securities for up to EUR 150 Million Capital Structure Not in shareholders’ best interests as this authority does not reflect international best practice.	Against	France
25/04/2013 Annual/Special	Bouygues	27	Approve Employee Stock Purchase Plan Executive Incentive Schemes The dilution limits under this scheme exceeded best practice guidelines, we were therefore unsupportive.	Against	France
25/04/2013 Annual/Special	Bouygues	28	Authorise up to 5 Percent of Issued Capital for Use in Restricted Stock Plan Capital Structure Not in shareholders’ best interests as this authority does not reflect international best practice.	Against	France
25/04/2013 Annual/Special	Bouygues	29	Authorise Board to Issue Free Warrants with Preemptive Rights During a Public Tender Offer Poison Pills/Anti-takeover devices We did not believe this to be in the best interests of all shareholders	Against	France
25/04/2013 Annual/Special	Bouygues	30	Allow Board to Use All Outstanding Capital Authorizations in the Event of a Public Tender Offer or Share Exchange Offer Poison Pills/Anti-takeover devices We did not believe this to be in the best interests of all shareholders	Against	France
25/04/2013 Annual	Colt Group SA	6	Approve Remuneration Report Executive Incentive Schemes This incentive scheme is not aligned with the interests of shareholders as it allows awards to vest after less than three years.	Against	United Kingdom
25/04/2013 Annual	Colt Group SA	24	Amend Share Grant Plan Remuneration Report We oppose rises in bonus potential that are not matched by a commensurate rise in performance hurdle.	Against	United Kingdom
25/04/2013 Annual/Special	Compagnie Plastic Omnium	8	Authorise Issuance of Equity or Equity-Linked Securities with Pre-emptive Rights up to Aggregate Nominal Amount of EUR 300 Million Capital Structure Not in shareholders’ best interests as this authority does not reflect international best practice.	Against	France
25/04/2013 Annual/Special	Compagnie Plastic Omnium	9	Authorise Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Above Capital Structure Not in shareholders’ best interests as this authority does not reflect international best practice.	Against	France
25/04/2013 Annual/Special	Compagnie Plastic Omnium	10	Authorise up to 2.5 Percent of Issued Capital for Use in Stock Option Plan Authorise Issued Capital for use in Incentive Plan The underlying features of this scheme did not reflect international best practice. We therefore did not support this authority to allocate shares to the scheme.	Against	France
25/04/2013 Annual/Special	Compagnie Plastic Omnium	11	Authorise up to 2.5 Percent of Issued Capital for Use in Restricted Stock Plan Authorise Issued Capital for use in Incentive Plan The underlying features of this scheme did not reflect international best practice. We therefore did not support this authority to allocate shares to the scheme.	Against	France
25/04/2013 Annual	Sandvik AB	17	Spin-off and Listing of Sandvik Materials Technology on the Stock Exchange; Distribute Shares to Sandvik's Shareholders Shareholder Proposal Not in shareholders’ best interests.	Against	Sweden
25/04/2013 Annual/Special	Schneider Electric SA	34	Elect Claude Briquet as Representative of Employee Shareholders to the Board Elect Employee Shareholder Representative Shareholders are required to elect only one employee representative to the board. It is our view that this nominee did not represent the best interests of shareholders.	Against	France
25/04/2013 Annual/Special	Schneider Electric SA	36	Elect Thierry Jacquet as Representative of Employee Shareholders to the Board Elect Employee Shareholder Representative Shareholders are required to elect only one employee representative to the board. It is our view that this nominee did not represent the best interests of shareholders.	Against	France
25/04/2013 Annual/Special	Schneider Electric SA	37	Elect Jean-Michel Vedrine as Representative of Employee Shareholders to the Board Elect Employee Shareholder Representative Shareholders are required to elect only one employee representative to the board. It is our view that this nominee did not represent the best interests of shareholders.	Against	France
25/04/2013 Annual/Special	Scor SE	4	Approve Auditors' Special Report on Related-Party Transactions Related Party Transactions We did not believe this to be in the best interests of all shareholders, however we accepted that the company had made some improvements during the year, and we were able to abstain.	Abstain	France
25/04/2013 Annual/Special	Scor SE	22	Authorise up to 1 Million of Shares for Use in Stock Option Plan Authorise Issued Capital for use in Incentive Plan The underlying features of this scheme did not reflect international best practice. However we acknowledged some points of explanation provided by the company in this case, and took into account that the company had provided better disclosure on this issue than many of its peers.	Abstain	France
25/04/2013 Annual/Special	Scor SE	23	Authorise up to 4 Million of Shares for Use in Restricted Stock Plan Authorise Issued Capital for use in Incentive Plan The underlying features of this scheme did not reflect international best practice. However we acknowledged some points of explanation provided by the company in this case, and took into account that the company had provided better disclosure on this issue than many of its peers.	Abstain	France
25/04/2013 Annual	Taylor Wimpey plc	16	Approve Remuneration Report Remuneration Report We did not feel that the proposed increase in bonus potential was justified by corporate performance in recent years and therefore abstained on the approval of the remuneration report.	Abstain	United Kingdom
25/04/2013 Annual/Special	UCB SA	E.2	Authorise Board to Increase Authorised Capital up to EUR 500 Million, Including by way of Issuance of Warrants or Convertible Bonds Increase in Capital The potential dilution from this increase is against best practice guidelines, therefore we were unsupportive.	Against	Belgium
25/04/2013 Annual/Special	UCB SA	E.3	Authorise Board to Issue Warrants/ Convertible Bonds in the Event of a Public Tender Offer or Share Exchange Offer Up to EUR 500 Million and Amend Articles Accordingly Poison Pills/Anti-takeover devices We did not believe this to be in the best interests of all shareholders	Against	Belgium
25/04/2013 Annual/Special	UCB SA	E.5	Authorise Board to Repurchase and to Reissue Shares in the Event of a Serious and Imminent Harm and Amend Articles Accordingly Poison Pills/Anti-takeover devices We did not believe this to be in the best interests of all shareholders	Against	Belgium
25/04/2013 Annual/Special	UCB SA	E.6	Authorise Repurchase of Up to 20 Percent of Issued Share Capital if Item E.5 is not Approved Share Repurchase The structure of this authority was against best practice guidelines, therefore we were unsupportive.	Against	Belgium
26/04/2013 Annual/Special	L Oreal	10	Authorise up to 0.6 Percent of Issued Capital for Use in Restricted Stock Plan Executive Incentive Schemes The structure of this scheme is not aligned with the interests of shareholders	Against	France
26/04/2013 Annual	Pearson plc	13	Approve Remuneration Report Remuneration Report Remuneration policies are not aligned with our interests as shareholders.	Abstain	United Kingdom
29/04/2013 Annual/Special	Compagnie industrielle et financiere d ingenierie Ingenico	6	Approve Severance Payment Agreement with Philippe Lazare Related Party Transactions We did not believe this to be in the best interests of all shareholders	Against	France
29/04/2013 Annual/Special	Compagnie industrielle et financiere d ingenierie Ingenico	10	Authorise Repurchase of Up to 10 Percent of Issued Share Capital Poison Pills/Anti-takeover devices We did not believe this to be in the best interests of all shareholders	Against	France
29/04/2013 Annual/Special	Compagnie industrielle et financiere d ingenierie Ingenico	23	Allow Board to Use All Authorisations and/or Delegations in the Event of a Public Tender Offer Poison Pills/Anti-takeover devices We did not believe this to be in the best interests of all shareholders	Against	France
29/04/2013 Annual	Luxottica Group S.p.A.	3	Approve Performance Shares Plan 2013-2017 Executive Incentive Schemes The structure of this scheme is not aligned with the interests of shareholders	Against	Italy
30/04/2013 Annual/Special	Atlantia SPA	2	Authorise Share Repurchase Program and Reissuance of Repurchased Shares Share Repurchase The structure of this authority was against best practice guidelines, therefore we were unsupportive.	Against	Italy
30/04/2013 Annual/Special	Atlantia SPA	4	Approve Remuneration Report Remuneration Report/Policy Insufficient disclosure of the features of remuneration policy.	Against	Italy
30/04/2013 Annual/Special	Atlantia SPA	5	Amend Equity Compensation Plans Executive Incentive Schemes Performance conditions were considered undemanding and there was no cap on the size of award that could be made to individuals.	Against	Italy
30/04/2013 Annual	Deutz AG	6	Approve Remuneration System for Management Board Members Executive Incentive Schemes There is a lack of cap on the size of the awards.	Against	Germany
30/04/2013 Annual/Special	Renault	15	Authorise up to 1.5 Percent of Issued Capital for Use in Restricted Stock Plan Executive Incentive Schemes Lack of disclosure on performance criteria	Abstain	France
30/04/2013 Annual/Special	Vivendi	3	Approve Auditors' Special Report on Related-Party Transactions Related Party Transactions We did not believe this to be in the best interests of all shareholders	Against	France

We use cookies and similar technologies

Our voting records

Search our voting records

Search

Shareholder Proposal

Shareholder Proposal

Shareholder Proposal

Remuneration Report

Re-elect Director

Re-elect Director

Re-elect Director

Re-elect Director

Related Party Transactions

Poison Pills/Anti-takeover devices

Remuneration Report

Remuneration Report

Remuneration Report

Remuneration Report

Remuneration Report

Related Party Transactions

Amend Articles/Bylaws

Poison Pills/Anti-takeover devices

Capital Structure

Capital Structure

Capital Structure

Capital Structure

Executive Incentive Schemes

Executive Incentive Schemes

Related Party Transactions

Capital Structure

Capital Structure

Capital Structure

Capital Structure

Capital Structure

Executive Incentive Schemes

Amend Articles/Bylaws

Ex-gratia Payments

Slate Nominees

Slate Nominees

Amend Articles/Bylaws

Amend Articles/Bylaws

Executive Incentive Schemes

Authorise Issued Capital for use in Incentive Plan

Poison Pills/Anti-takeover devices

Amend Articles/Bylaws

Share Repurchase

Option awards to Non-executive Directors

Option awards to Non-executive Directors

Option awards to Non-executive Directors

Option awards to Non-executive Directors

Option awards to Non-executive Directors

Remuneration Report

Executive Incentive Schemes

Executive Incentive Schemes

Remuneration Report

Related Party Transactions

Poison Pills/Anti-takeover devices

Capital Structure

Capital Structure

Capital Structure

Capital Structure

Capital Structure

Capital Structure

Executive Incentive Schemes

Capital Structure

Poison Pills/Anti-takeover devices

Poison Pills/Anti-takeover devices

Executive Incentive Schemes

Remuneration Report

Capital Structure

Capital Structure

Authorise Issued Capital for use in Incentive Plan

Authorise Issued Capital for use in Incentive Plan

Shareholder Proposal

Elect Employee Shareholder Representative

Elect Employee Shareholder Representative

Elect Employee Shareholder Representative

Related Party Transactions

Authorise Issued Capital for use in Incentive Plan

Authorise Issued Capital for use in Incentive Plan